SCHEMBL84059

SCHEMBL84059

C=P(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20882127 0.72
SCHEMBL20726613 0.72
SCHEMBL8290749 0.72
SCHEMBL14049359 0.72
SCHEMBL12709253 0.72
SCHEMBL24512439 0.72
SCHEMBL15837308 0.72
SCHEMBL20726609 0.65
SCHEMBL12189873 0.65
SCHEMBL15444743 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 524 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050028670-A1 Ionically crosslinked molecular thin film REGEN STEVEN L (US) 2005-02-10 US claimed
US-20240239752-A1 BICYCLIC HETEROAROMATIC INHIBITORS OF KLK5 WILMINGTON TRUST, NATIONAL ASSOCIATION 2024-07-18 US disclosed
US-11873316-B2 Compositions and methods for phosphoramidite and oligonucleotide synthesis WAVE LIFE SCIENCES LTD. (SG) 2024-01-16 US disclosed
US-11834482-B2 Agents modulating beta-catenin functions and methods thereof FOG PHARMACEUTICALS, INC. (US) 2023-12-05 US disclosed
US-11826485-B2 Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices HYPERBRANCH MEDICAL TECHNOLOGY, INC. (US) 2023-11-28 US disclosed
US-11807605-B2 Human plasma kallikrein inhibitors BIOCRYST PHARMACEUTICALS, INC. (US) 2023-11-07 US disclosed
US-20230348524-A1 TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION WAVE LIFE SCIENCES LTD. (SG) 2023-11-02 US disclosed
US-20230330240-A1 TECHNOLOGIES FOR PREVENTING OR TREATING INFECTIONS BIOHAVEN THERAPEUTICS LTD (US) 2023-10-19 US disclosed
US-20230323344-A1 POLYNUCLEOTIDES CONTAINING A MORPHOLINO LINKER ARES CAPITAL CORPORATION, AS AGENT 2023-10-12 US disclosed
US-20230293566-A1 N4-Hydroxycytidine and Derivatives and Anti-Viral Uses Related Thereto EMORY UNIVERSITY 2023-09-21 US disclosed
EP-0400972-A2 Fluorescent degree of cure monitors MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1990-12-05 EP disclosed
EP-0374627-A2 Highly effective polarisers BAYER AG (DE) 1990-06-27 EP disclosed
EP-0374626-A2 Laminated polarisers BAYER AG (DE) 1990-06-27 EP disclosed
EP-0249019-B1 POLARIZERS BASED ON POLYACETYLENE AND THEIR FABRICATION BAYER AG (DE) 1990-06-06 EP disclosed
US-4893911-A Polarizers based on polyacetylene, and the production thereof BAYER AKTIENGESELLSCHAFT (DE) 1990-01-16 US disclosed
EP-0249019-A1 Polarizers based on polyacetylene and their fabrication BAYER AG (DE) 1987-12-16 EP disclosed
EP-0210498-A2 Process for the polymerization of acetylene in the presence of polymers, and polymer products containing polyacetylene BAYER AG (DE) 1987-02-04 EP disclosed
EP-0101927-B1 ORGANIC NICKEL COMPOUNDS, THEIR PREPARATION AND USE AS CATALYSTS IN THE POLYMERISATION OF OLEFINES BAYER AG (DE) 1986-03-05 EP disclosed
EP-0101927-A1 Organic nickel compounds, their preparation and use as catalysts in the polymerisation of olefines BAYER AG (DE) 1984-03-07 EP disclosed
US-3988332-A Hydrocarbylidene compounds of niobium and tantalum E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-10-26 US disclosed